Open AccessAbstract 5017: EphA2 is a clinically relevant target for breast cancer bone metastatic disease
Author(s) -
Dana M. Brantley-Sieders
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-5017
Subject(s) - osteolysis , medicine , breast cancer , metastasis , eph receptor a2 , metastatic breast cancer , bone metastasis , cancer research , cancer , pathology , oncology , in vivo , bone disease , receptor tyrosine kinase , receptor , biology , surgery , microbiology and biotechnology , osteoporosis